LOS ANGELES, Oct. 10, 2018 /PRNewswire-PRWeb/ -- A non-invasive device has been developed to alleviate symptoms of carpal tunnel syndrome and is being investigated in an NIH-funded clinical trial. If you have been diagnosed with carpal tunnel syndrome and have the diagnosis confirmed via a nerve conduction study, then you may be eligible to join this study.
Enrollment is nationwide and the study is conducted remotely, which means you can participate from the comfort of your home in the U.S. The primary eligibility requirement is that you have been diagnosed with carpal tunnel syndrome in the past 12 months.
The trial involves simply wearing the study device on the wrist daily for 2 months, followed by 3 months of online follow-up. During the study, you would need to fill out a daily usage log and periodic online surveys to evaluate changes in your CTS symptoms.
As this is a research study so you may or may not receive any direct health benefits as a result of your participation, and you will be compensated $300 upon completion of the study. The trial is limited to 100 participants so we encourage you to visit the study website at http://www.carpaltunneltrial.com and sign up before the spaces are filled.
Research reported in this publication was supported by the National Institute Of Biomedical Imaging And Bioengineering of the National Institutes of Health under Award Number R44EB024713. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About PPS:
PPS was founded over 20 years ago based on tactile sensor technology for robotics at Harvard University. Since then, PPS has expanded to develop innovative medical devices and solutions involving the sense of touch for fortune 100 companies as well as incubating and spinning off medical product companies. Dr. Jae Son invented the product though his company PPS. Research collaborators include Cleveland Clinic, Mission Pain and Spine, and Kaiser Permanente.
PPS will be at the 2018 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Washington, D.C., on October 12, and at the 2018 American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly in Orlando, FL, on October 25-26
For more information: http://www.carpaltunneltrial.com https://clinicaltrials.gov/ct2/show/NCT03498287
SOURCE PPS
Advertisement
Enrollment is nationwide and the study is conducted remotely, which means you can participate from the comfort of your home in the U.S. The primary eligibility requirement is that you have been diagnosed with carpal tunnel syndrome in the past 12 months.
Advertisement
The trial involves simply wearing the study device on the wrist daily for 2 months, followed by 3 months of online follow-up. During the study, you would need to fill out a daily usage log and periodic online surveys to evaluate changes in your CTS symptoms.
As this is a research study so you may or may not receive any direct health benefits as a result of your participation, and you will be compensated $300 upon completion of the study. The trial is limited to 100 participants so we encourage you to visit the study website at http://www.carpaltunneltrial.com and sign up before the spaces are filled.
Research reported in this publication was supported by the National Institute Of Biomedical Imaging And Bioengineering of the National Institutes of Health under Award Number R44EB024713. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
About PPS:
PPS was founded over 20 years ago based on tactile sensor technology for robotics at Harvard University. Since then, PPS has expanded to develop innovative medical devices and solutions involving the sense of touch for fortune 100 companies as well as incubating and spinning off medical product companies. Dr. Jae Son invented the product though his company PPS. Research collaborators include Cleveland Clinic, Mission Pain and Spine, and Kaiser Permanente.
PPS will be at the 2018 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Washington, D.C., on October 12, and at the 2018 American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly in Orlando, FL, on October 25-26
For more information: http://www.carpaltunneltrial.com https://clinicaltrials.gov/ct2/show/NCT03498287
SOURCE PPS
